IL134880A0 - A method of diagnosis - Google Patents

A method of diagnosis

Info

Publication number
IL134880A0
IL134880A0 IL13488098A IL13488098A IL134880A0 IL 134880 A0 IL134880 A0 IL 134880A0 IL 13488098 A IL13488098 A IL 13488098A IL 13488098 A IL13488098 A IL 13488098A IL 134880 A0 IL134880 A0 IL 134880A0
Authority
IL
Israel
Prior art keywords
predicting
development
lung damage
damage
diagnosing
Prior art date
Application number
IL13488098A
Other languages
English (en)
Original Assignee
Univ Southern Australia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AUPO8999A external-priority patent/AUPO899997A0/en
Priority claimed from AUPP5062A external-priority patent/AUPP506298A0/en
Application filed by Univ Southern Australia filed Critical Univ Southern Australia
Publication of IL134880A0 publication Critical patent/IL134880A0/xx

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/785—Alveolar surfactant peptides; Pulmonary surfactant peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/811—Test for named disease, body condition or organ function

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Investigating Or Analyzing Materials By The Use Of Ultrasonic Waves (AREA)
  • Analysing Materials By The Use Of Radiation (AREA)
  • Control Of Eletrric Generators (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Diaphragms For Electromechanical Transducers (AREA)
  • Vehicle Body Suspensions (AREA)
  • Oscillators With Electromechanical Resonators (AREA)
IL13488098A 1997-09-05 1998-09-04 A method of diagnosis IL134880A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AUPO8999A AUPO899997A0 (en) 1997-09-05 1997-09-05 A method of diagnosis
AUPP5062A AUPP506298A0 (en) 1998-08-04 1998-08-04 A method of diagnosis - II
PCT/AU1998/000723 WO1999013337A1 (en) 1997-09-05 1998-09-04 A method of diagnosis

Publications (1)

Publication Number Publication Date
IL134880A0 true IL134880A0 (en) 2001-05-20

Family

ID=25645598

Family Applications (3)

Application Number Title Priority Date Filing Date
IL13488098A IL134880A0 (en) 1997-09-05 1998-09-04 A method of diagnosis
IL134880A IL134880A (en) 1997-09-05 2000-03-05 Method of diagnosing lung damage
IL172185A IL172185A0 (en) 1997-09-05 2005-11-24 Method of diagnosis lung damage

Family Applications After (2)

Application Number Title Priority Date Filing Date
IL134880A IL134880A (en) 1997-09-05 2000-03-05 Method of diagnosing lung damage
IL172185A IL172185A0 (en) 1997-09-05 2005-11-24 Method of diagnosis lung damage

Country Status (10)

Country Link
US (1) US8097420B1 (de)
EP (1) EP1018018B1 (de)
JP (2) JP4584445B2 (de)
AT (1) ATE476662T1 (de)
CA (1) CA2303169C (de)
DE (1) DE69841804D1 (de)
DK (1) DK1018018T3 (de)
IL (3) IL134880A0 (de)
NZ (1) NZ503175A (de)
WO (1) WO1999013337A1 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2101496B1 (de) 1996-02-28 2013-01-23 Panasonic Corporation Optische Platte mit hoher Auflösung zum Aufzeichnen von stereoskopischem Video, Vorrichtung zur Wiedergabe einer optischen Platte und Vorrichtung zum Aufzeichnen auf einer optischen Platte
WO2004077056A1 (en) * 2003-02-27 2004-09-10 Lung Health Diagnostics Pty. Ltd. A method of diagnosis and agents useful for same
SE0203591D0 (sv) * 2002-12-04 2002-12-04 Siemens Elema Ab Förfarande för beredning av ett mediakament och en medicinsk anordning
EP1522857A1 (de) * 2003-10-09 2005-04-13 Universiteit Maastricht Methode zur Feststellung des Risikos von Herzversagen in einem Individuum durch Bestimmung der Menge an Galectin-3 oder Thrombospondin-2
US7659087B2 (en) * 2004-07-23 2010-02-09 Aspenbio Pharma, Inc. Methods and devices for diagnosis of appendicitis
EP1845379A1 (de) * 2006-04-13 2007-10-17 F. Hoffmann-La Roche AG Mittel und Verfahren zur Differenzierung kardialer und pulmonaler Ursachen von Atemnot
EP1882945A1 (de) 2006-07-28 2008-01-30 F.Hoffmann-La Roche Ag Vorrichtungen und Verfahren zur Differentierung zwischen herz- und lungenbedingten Ursachen für akute Atemnot
EP2031397A1 (de) 2007-08-30 2009-03-04 F. Hoffmann-La Roche AG Surfactantproteine B und D bei der Unterscheidung der Ursachen für Atemnot
CN101938939B (zh) * 2008-02-07 2014-11-26 皇家飞利浦电子股份有限公司 用于测量和预测患者呼吸稳定性的装置
WO2012130731A1 (en) 2011-03-25 2012-10-04 Roche Diagnostics Gmbh MEASUREMENT OF C-TERMINAL proSP-B
CN102552879B (zh) * 2012-03-15 2013-11-06 北京双鹤现代医药技术有限责任公司 肺表面活性提取物与肺表面活性物质相关蛋白a的组合物、制备方法及其制药用途
EP2650684A1 (de) 2012-04-10 2013-10-16 Roche Diagniostics GmbH Diagnose auf Pro-SP-B und NT-proBNP bei Patienten mit Lungenentzündung
EP2615459A1 (de) 2012-04-27 2013-07-17 Roche Diagniostics GmbH Verfahren zur Diagnose von Distalbronchoalveolargewebeschäden in Asthma durch Erkennen von proSP-B
EP2866033A1 (de) 2013-10-23 2015-04-29 Roche Diagniostics GmbH Differenzialdiagnose von akuter Atemnot auf Basis von c-terminiertem proSP-B, KL-6 und BNP-Peptiden
GB201511207D0 (en) * 2015-06-25 2015-08-12 Xvivo Perfusion Ab Isolated organ evaluation and treatment
EP3287921B1 (de) * 2016-08-26 2020-11-04 Nxp B.V. Gesprochener pass-satz zur bestimmung der eignung

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3650147T2 (de) * 1985-05-31 1995-04-06 Teijin Ltd Verfahren zur bestimmung menschlicher lungenoberflächenaktiver substanz und reagenziensatz dazu.
KR920001533B1 (ko) 1987-09-01 1992-02-18 데이진 가부시끼가이샤 인간 폐표면 활성물질의 측정방법
JP2517696B2 (ja) * 1990-04-27 1996-07-24 帝人株式会社 肺疾患マ―カ―蛋白の測定法
ES2093778T3 (es) 1991-04-26 1997-01-01 Surface Active Ltd Nuevos anticuerpos y metodos para su uso.
US5670328A (en) 1992-06-09 1997-09-23 Yamasa Corporation Monoclonal antibodies to human pulmonary surfactant apoprotein D and use thereof
DE69333283T2 (de) * 1992-06-09 2004-08-26 Yamasa Corp., Chishi Lungenkrankheiten screening durch messung der HUMANES OBERFLÄCHENAKTIVES APOPROTEIN D DER LUNGE
ATE292800T1 (de) 1998-07-24 2005-04-15 Altana Pharma Ag Immunologische bestimmung des hydrophoben lungensurfaktantproteins sp-c
US7713705B2 (en) 2002-12-24 2010-05-11 Biosite, Inc. Markers for differential diagnosis and methods of use thereof

Also Published As

Publication number Publication date
JP4584445B2 (ja) 2010-11-24
IL134880A (en) 2006-12-10
DE69841804D1 (de) 2010-09-16
EP1018018A1 (de) 2000-07-12
JP2010197405A (ja) 2010-09-09
HK1029622A1 (en) 2001-04-06
EP1018018B1 (de) 2010-08-04
JP2001516057A (ja) 2001-09-25
US8097420B1 (en) 2012-01-17
EP1018018A4 (de) 2004-12-22
NZ503175A (en) 2002-11-26
ATE476662T1 (de) 2010-08-15
CA2303169C (en) 2009-11-10
CA2303169A1 (en) 1999-03-18
WO1999013337A1 (en) 1999-03-18
IL172185A0 (en) 2009-02-11
DK1018018T3 (da) 2010-11-15

Similar Documents

Publication Publication Date Title
IL134880A0 (en) A method of diagnosis
DK1328421T3 (da) Fremgangsmåde og apparat til vurdering og forbedring af en førers arbejdspræstation
WO2003069332A3 (en) Detection and/or monitoring of synuclein-related diseases
DE69821931D1 (de) System zum genauen überwachen des kardiovaskulären zustandes eines lebewesens
ZA964819B (en) Aminosterol compounds useful as inhibitors of the sodium/proton exchanger (NHE), pharmaceutical methods and compositions employing such inhibitors, and processes for evaluating the NHE-inhibitory efficacy of compounds.
DE69502319D1 (de) System zum Uberprüfen der Anwesenheit des Bedieners für einen Bedienersitz
DE60218863D1 (de) Herz-lungen-überwachungsgerät
EA199800667A1 (ru) Новые фенантридины
CY1109062T1 (el) Μεθοδοι ανιχνευσεως και αναστολης της αγγειογενεσεως
CA2255023A1 (en) A method and system for monitoring the execution of hybrid source code
WO2000018899A3 (en) Angiotensin converting enzyme homolog and its use
WO2002056749A3 (en) Diagnostic and monitoring methods for cancer
ES2148967T3 (es) Sustancias y metodos destinados al diagnostico y al tratamiento de la pre-eclampsia.
ZA964818B (en) Aminosterol compounds useful as inhibitors of the sodium/proton exchanger (NHE), pharmaceutical methods and compositions employing such inhibitors, and processes for evaluating the NHE-inhibitory efficacy of compounds.
AU2003217652A8 (en) Methods for continuous performance testing
BR0207548A (pt) Método de controle de poeira automatizado
MY120237A (en) Method for the synthesis of quinoline derivatives
WO1998041238A3 (en) Methods and kits for treating and diagnosing leiomyomas
DE69508605D1 (de) Proinsulin-peptid-verbindungen für den nachweis und die behandlung von typ-i-diabetes
CA2091637A1 (en) Call Progress Monitoring
CA2334910A1 (en) New use of a pyridazinone derivative
DE69606609D1 (de) Wandleranordnung für akustische Abbildung
ES2187552T3 (es) Un sistema de medicion, principalmente ambulatoria, por medio de un electrodo.
FR2760862B1 (fr) Procede de diagnostic dynamique d'un actionneur
NO20002176D0 (no) Diagnostikk og terapi av kronisk obstruktiv luftveissykdom

Legal Events

Date Code Title Description
KB Patent renewed
FF Patent granted
KB Patent renewed